This inventor holds 1 USPTO granted patent and 2 published patent applications. Top assignee: Octapharma Ag. Active years: 2023.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2023
Title: Lars Stoeckl: Innovator in Genetic Modification
Introduction
Lars Stoeckl is a prominent inventor based in Lachen, Switzerland. He has made significant contributions to the field of genetic engineering, particularly through his innovative methods involving CRISPR technology. His work focuses on modifying multiple alleles in genes, which has important implications for therapeutic applications.
Latest Patents
Lars Stoeckl holds a patent titled "Means and methods for modifying multiple alleles." This invention relates to a method of modifying at least one gene in a cell via CRISPR/Cas, wherein the gene has at least three alleles. The patent also covers cells that can be obtained through this method. Furthermore, it provides a method for producing proteins in cells modified by this technique, which can be utilized in various therapeutic contexts.
Career Highlights
Lars Stoeckl is associated with Octapharma AG, a company known for its focus on human proteins and innovative therapies. His work at Octapharma AG has allowed him to apply his research in practical settings, contributing to advancements in medical treatments.
Collaborations
Lars collaborates with talented individuals such as Karina Nawrath and Janine Guendel. Their combined expertise enhances the research and development efforts at Octapharma AG.
Conclusion
Lars Stoeckl's innovative work in genetic modification through CRISPR technology positions him as a key figure in the field. His contributions have the potential to lead to significant advancements in therapeutic applications.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile